Bruno V, Battaglia G, Copani A, Cespédes V M, Galindo M F, Ceña V, Sánchez-Prieto J, Gasparini F, Kuhn R, Flor P J, Nicoletti F
I.N.M. Neuromed, Località Camerelle, 86077 Pozzilli, Italy.
Eur J Neurosci. 2001 Apr;13(8):1469-78. doi: 10.1046/j.0953-816x.2001.01541.x.
Activation of group I metabotropic glutamate receptors (mGlu1 or -5 receptors) is known to either enhance or attenuate excitotoxic neuronal death depending on the experimental conditions. We have examined the possibility that these receptors may switch between two different functional modes in regulating excitotoxicity. In mixed cultures of cortical cells, the selective mGlu1/5 agonist, 3,5-dihydroxyphenylglycine (DHPG), amplified neurodegeneration induced by a toxic pulse of NMDA. This effect was observed when DHPG was either combined with NMDA or transiently applied to the cultures prior to the NMDA pulse. However, two consecutive applications of DHPG consistently produced neuroprotection. Similar effects were observed with DHPG or quisqualate (a potent agonist of mGlu1/5 receptors) in pure cultures of cortical neurons virtually devoid of astrocytes. In cultures of hippocampal pyramidal neurons, however, only protective effects of DHPG were seen suggesting that, in these particular cultures, group I mGlu receptors were endogenously switched into a "neuroprotective mode". The characteristics of the activity-dependent switch from facilitation to inhibition were examined in mixed cultures of cortical cells. The switch in the response to DHPG was observed when the two applications of the drug were separated by an interval ranging from 1-45 min, but was lost when the interval was extended to 90 min. In addition, this phenomenon required the initial activation of mGlu5 receptors (as indicated by the use of subtype-selective antagonists) and was mediated by the activation of protein kinase C. We conclude that group I mGlu receptors are subjected to an activity-dependent switch in regulating excitotoxic neuronal death and, therefore, the recent "history" of these receptors is critical for the response to agonists or antagonists.
已知I组代谢型谷氨酸受体(mGlu1或-5受体)的激活根据实验条件可增强或减弱兴奋性毒性神经元死亡。我们研究了这些受体在调节兴奋性毒性时可能在两种不同功能模式之间切换的可能性。在皮质细胞的混合培养物中,选择性mGlu1/5激动剂3,5-二羟基苯甘氨酸(DHPG)放大了由NMDA毒性脉冲诱导的神经退行性变。当DHPG与NMDA联合使用或在NMDA脉冲之前短暂应用于培养物时,观察到这种效应。然而,连续两次应用DHPG始终产生神经保护作用。在几乎没有星形胶质细胞的皮质神经元纯培养物中,用DHPG或喹啉酸(mGlu1/5受体的强效激动剂)也观察到了类似的效果。然而,在海马锥体神经元培养物中,仅观察到DHPG的保护作用,这表明在这些特定培养物中,I组mGlu受体内源性地切换到了“神经保护模式”。在皮质细胞的混合培养物中研究了活性依赖性从促进到抑制转换的特征。当两次药物应用之间的间隔为1-45分钟时,观察到对DHPG反应的转换,但当间隔延长至90分钟时则消失。此外,这种现象需要mGlu5受体的初始激活(如使用亚型选择性拮抗剂所示),并由蛋白激酶C的激活介导。我们得出结论,I组mGlu受体在调节兴奋性毒性神经元死亡时经历活性依赖性转换,因此,这些受体的近期“历史”对于对激动剂或拮抗剂的反应至关重要。